Healthcare -
Biotechnology - NASDAQ - US
$ 2.725
0.408 %
$ 174 M
Market Cap
-1.63
P/E
LRMR - CASH FROM OPERATIONS
Cash from Operations LRMR - Larimar Therapeutics, Inc.
-70.8 M
LAST VALUE
-60.21%
2 YEAR CAGR
-25.53%
5 YEAR CAGR
-9.62%
10 YEAR CAGR